Skip Navigation


Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Basic Science

Therapeutic Vaccines and Immunotherapy

NIAID currently supports both research and early stage development of therapeutic vaccine concepts and new immune based therapies through the innovation grant program, investigator-initiated grants and cooperative agreements, and vaccine teams contracts. Areas of interest include any specific therapeutic vaccine concept that is compatible with current antiretroviral therapy and that can be pursued in well-planned preclinical studies. Mature programs that are supported by a vaccine teams contract need to be highly focused, managed, multidisciplinary, and targeted to the development effort that will culminate in the production and clinical testing of the AIDS therapeutic vaccine candidate.

Last Updated February 27, 2007